1093066-74-0

Basic information

• Product Name: tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate
• Synonyms: tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate
• CAS NO: 1093066-74-0
• Molecular Formula: C13H22F2N2O2
• Molecular Weight: 276.3227864
• Mol File: 1093066-74-0.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 319.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.18±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 4.47±0.40(Predicted)
• CAS DataBase Reference: tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate(1093066-74-0)
• EPA Substance Registry System: tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate(1093066-74-0)

Safety Data

• Hazardous Substances Data: 1093066-74-0(Hazardous Substances Data)

Usage

General Description

Tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate is a chemical compound with the formula C14H24F2N2O2. It is a piperidine derivative with a tert-butyl ester group and a difluoroazetidine moiety. tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate is used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It has the potential to be used in the development of novel drugs and research into the biological effects of piperidine derivatives. Tert-Butyl 4-(3,3-difluoroazetidin-1-yl)piperidine-1-carboxylate is a valuable building block for the preparation of diverse chemical compounds in the pharmaceutical and biotechnology industries.

Upstream product

• 288315-03-7 3,3-difluoroazetidine hydrochloride 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 1093066-73-9 4-(3,3-difluoroazetidin-1-yl)piperidine 

Relevant articles and documents

MUSCARINIC AGONISTS

This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1 or a salt thereof, wherein q, r, s, Q, R1, R2', R2 , R3 and R4 are as defined herein.

PURINE DERIVATIVES USEFUL AS PI3 KINASE INHIBITORS

This invention provides a compound which is a purine of formula (Ia) or (Ib): and the pharmaceutically acceptable salts thereof that are inhibitors of PI3K and a selective for the p110δ isoform, which is a class Ia PI3 kinase, over other class Ia PI3 kinases and over class Ib kinases. The compounds may be used to treat diseases and disorders arisi from abnormal cell growth, function or behaviour associated with PI3 kinase such as cance immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.